Neu: Nutzen Sie neue Funktionen auf finanzen.net als Erstes - hier informieren!
17.05.2022 15:07

Cross Country Healthcare and AnheuserBusch InBev have been highlighted as Zacks Bull and Bear of the Day

Folgen
Werbung
For Immediate ReleaseChicago, IL – May 17, 2022 – Zacks Equity Research Cross Country Healthcare CCRN  as the Bull of the Day and AnheuserBusch InBev BUD asthe Bear of the Day. In addition, Zacks Equity Research provides analysis on Walmart's WMT, Macy's M and Home Depot HDHere is a synopsis of all five stocks:Bull of the Day:Cross Country Healthcare is a Zacks Rank #1 (Strong Buy) that recently reported a strong quarter but this stock has been sliding.  The pandemic certainly caused demand and wages for healthcare professionals to soar, but is that run over?  Let's explore more about this stock in this Bull Of The Day article.DescriptionCross Country Healthcare, Inc. is a national leader in providing innovative healthcare workforce solutions and staffing services. Their diverse client base includes both clinical and nonclinical settings, servicing acute care hospitals, physician practice groups, outpatient and ambulatory-care centers, nursing facilities, both public schools and charter schools, rehabilitation and sports medicine clinics, government facilities, and homecare.They are able to place clinicians on travel and per diem assignments, local short-term contracts and permanent positions. They are a market leader in providing flexible workforce management solutions, which include managed services programs (MSP), internal resource pool consulting and development, electronic medical record (EMR) transition staffing, recruitment process outsourcing, predictive modeling and other outsourcing and consultative services.Earnings HistoryWhen I look at a stock, the first thing I do is look to see if the company is beating the number.  This tells me right away where the market's expectations have been for the company and how management has communicated to the market.  A stock that consistently beats has management communicating expectations to Wall Street that can be achieved.  That is what you want to see.For CCRN, I see four straight quarters where the company beat of the Zacks Consensus Estimate.  That is always good to see, but by itself that is not enough to make the company a Zacks Rank #1 (Strong Buy).The average positive earnings surprise over the course of the last year works out to be 29%.Earnings Estimates RevisionsThe Zacks Rank tells us which stocks are seeing earnings estimates move higher.  For PPC, I see annual estimates moving higher.Over the last 60 days, I see a few increases.The full fiscal year 2022 has moved from $2.49 to $4.57.Next has nearly doubled from $1.50 to $2.98.Positive movement in earnings estimates like that is why this stock is a Zacks Rank #1 (Strong Buy).ValuationI see a great valuation for CCRN.  The forward PE is 3.4x and that is  very low considering the 139% topline growth the company posted in the most recent quarter.  The price to book of 1.7x is very low given the growth in earnings.  The price to sales comes in at 0.28x, which is super low and indicates that the market does not value each sales dollar all that highly. Margins have increased in a big way over the last couple quarters, moving from 5.5% to 7.4%, and if they keep that up with solid revenue growth then earnings are going to be moving a lot higher.Bear of the Day:AnheuserBusch InBev is a Zacks Rank #5 (Strong Sell) despite beating the number in the most recent earnings release.  If we are in fact headed into a recession, then people are likely to have .  Let's look at why this stock is a Zacks Rank #5 (Strong Sell) and in this Bear of the Day article.DescriptionAnheuser-Busch InBev, alias AB InBev, is a global brewing company with more than 500 iconic brands. The company's leading position in the majority of its markets and a strong global footprint lends the advantage of economies of scale and growing its multi-country brands globally. Its strategy is based on efforts to develop a portfolio of brands that cater to extensive consumer needs within the market, in terms of price range, flavor profiles, and brand meaning.Earnings HistoryWhen I look at a stock, the first thing I do is look to see if the company is beating the number.  This tells me right away where the market's expectations have been for the company and how management has communicated to the market.  A stock that consistently beats has management communicating expectations to Wall Street that can be achieved.  That is what you want to see.In the case of BUD, I see two straight beats which preceded two straight misses of the  Zacks Consensus Estimate.   This alone does not make the stock a Zacks Rank #1 (Strong Buy) and it doesn't make it a Zacks Rank #5 (Strong Sell) either.The Zacks Rank does care about the earnings history, but it is much more heavily influenced by the movement of earnings estimates.Earnings EstimatesThe Zacks Rank tells us which stocks are seeing earnings estimates move higher or in this case lower.  For BUD I see annual estimates moving lower.The Zacks Rank is more heavily influenced by the move in the annual numbers, and the movement is mixed for those numbers.The current year 2022 consensus number has dropped from $3.16 to $3.07.The next year has dropped from $3.66 to $3.41 over the last 60 days.Negative movement in earnings estimates like that is why this stock is a Zacks Rank #5 (Strong Sell).It should be noted that a majority of stocks in the Zacks universe are seeing positive earnings estimate revisions.  That means that the stocks that are seeing small but negative earnings estimate revisions are falling to a Zacks Rank #5 (Strong Sell). Additional content:Markets Tepidly Mixed Ahead of Big-Box Retailer Earnings: WMT, M, HDThe blue-chip Dow 30 index rose for the second straight session this Monday, albeit by a very slim +0.08%. The other major market indexes were all down on the day, but only the tech-heavy Nasdaq sold off with any heft, -1.20% or -142 points. The S&P 500 and small-cap Russell 2000 dipped -0.39% and -0.52%, respectively.Bitcoin suffered again, dropping another -3.8% on the day, although this was off the -5% lows we saw as of Monday's closing bell. Year to date, the leading cryptocurrency has fallen -37%, which is still better than the -39% drop we've seen in Ethereum since the start of the year.Meanwhile, the spot price for gold is +11.7 on the day to 1823.90. It would appear the move to crypto as a safe-haven investment is not quite where many thought it was, and it certainly hasn't replaced investors' flight to safety into gold.And mortgage prices are now averaging 5.5% on a 30-year fixed loan — the highest they've been in many years. We'll get new Housing Starts/Building Permits data as well as Existing Home Sales later this week; it may be a tad early to see the effects of higher mortgage rates on housing prices and availability, but it is a space we're interested in tracking regarding overall inflation metrics.In the Ahead of Wall Street column from this morning, we discussed a bit about what to expect from Walmart's quarterly earnings report out early Tuesday. We also will hear from Macy's and Home Depot ahead of the opening bell, and here's what to look for in their respective Q1s:Both Macy's and Home Depot have strung together an impressive past five years of earnings reports — each only having missed one quarter that whole time. From there, however, the fortunes are expected to diverge quite widely. While Home Depot's earnings and sales in the quarter are both expected to be down low-to-mid single digits year over year, Macy's is looking to make a big move beyond its year-ago Covid levels, with revenues expected +13.6% and earnings +110% from last year's Q1.In fact, the trailing four-quarter average earnings beat for Macy's is a whopping +239%, while for Home Depot it's a still-respectable +11%. Both retailers are taking Zacks Rank #3 (Hold) ratings into their earnings releases.Questions or comments about this article and/or its author? Click here>>Why Haven't You Looked at Zacks' Top Stocks? Our 5 best-performing strategies have blown away the S&P's impressive +28.8% gain in 2021. Amazingly, they soared +40.3%, +48.2%, +67.6%, +94.4%, and +95.3%. Today you can access their live picks without cost or obligation.See Stocks Free >> Media ContactZacks Investment Research800-767-3771 ext. 9339https://www.zacks.comZacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.Past performance is no guarantee of future results. Inherent in any investment is the potential for loss.This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.Just Released: Zacks Top 10 Stocks for 2022In addition to the investment ideas discussed above, would you like to know about our 10 top picks for the entirety of 2022?From inception in 2012 through 2021, the Zacks Top 10 Stocks portfolios gained an impressive +1,001.2% versus the S&P 500’s +348.7%. Now our Director of Research has combed through 4,000 companies covered by the Zacks Rank and has handpicked the best 10 tickers to buy and hold. Don’t miss your chance to get in…because the sooner you do, the more upside you stand to grab.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Macy's, Inc. (M): Free Stock Analysis Report Walmart Inc. (WMT): Free Stock Analysis Report The Home Depot, Inc. (HD): Free Stock Analysis Report AnheuserBusch InBev SANV (BUD): Free Stock Analysis Report Cross Country Healthcare, Inc. (CCRN): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
Weiter zum vollständigen Artikel bei "Zacks"
Ausgewählte Hebelprodukte auf AB InBev SA-NV (Anheuser-Busch InBev)
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf AB InBev SA-NV (Anheuser-Busch InBev)
Long
Short
Hebel wählen:
5x
10x
Name
Hebel
KO
Emittent
Quelle: Zacks

Nachrichten zu AB InBev SA-NV (Anheuser-Busch InBev)

  • Relevant
  • Alle
  • vom Unternehmen
  • Peer Group
  • ?

Um Ihnen die Übersicht über die große Anzahl an Nachrichten, die jeden Tag für ein Unternehmen erscheinen, etwas zu erleichtern, haben wir den Nachrichtenfeed in folgende Kategorien aufgeteilt:

Relevant: Nachrichten von ausgesuchten Quellen, die sich im Speziellen mit diesem Unternehmen befassen

Alle: Alle Nachrichten, die dieses Unternehmen betreffen. Z.B. auch Marktberichte die außerdem auch andere Unternehmen betreffen

vom Unternehmen: Nachrichten und Adhoc-Meldungen, die vom Unternehmen selbst veröffentlicht werden

Peer Group: Nachrichten von Unternehmen, die zur Peer Group gehören

Analysen zu AB InBev SA-NV (Anheuser-Busch InBev)

  • Alle
  • Buy
  • Hold
  • Sell
  • ?
28.06.2022AB InBev SA-NV (Anheuser-Busch InBev) Equal-weightMorgan Stanley
08.06.2022AB InBev SA-NV (Anheuser-Busch InBev) NeutralGoldman Sachs Group Inc.
06.05.2022AB InBev SA-NV (Anheuser-Busch InBev) NeutralCredit Suisse Group
06.05.2022AB InBev SA-NV (Anheuser-Busch InBev) NeutralGoldman Sachs Group Inc.
05.05.2022AB InBev SA-NV (Anheuser-Busch InBev) NeutralGoldman Sachs Group Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für AB InBev SA-NV (Anheuser-Busch InBev) nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"

Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"

Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen
Werbung
Werbung
Werbung
Neue Funktionen als Erstes nutzen
Sie nutzen finanzen.net regelmäßig? Dann nutzen Sie jetzt neue Funktionen als Erstes!
Hier informieren!
Werbung
Börse Stuttgart Anlegerclub
Werbung

Heute im Fokus

Ukraine-Krieg im Ticker: DAX geht etwas fester ins Wochenende -- US-Börsen schließen stark-- Siemens nimmt Milliarden-Abschreibung auf Siemens Energy vor -- Commerzbank, TUI, JENOPTIK, BMW im Fokus

BMW: Empfindlicher Dämpfer bei US-Verkäufen. USA bestellt erneut Affenpocken-Impfstoff bei Bavarian Nordic. Porsche setzt in den USA im zweiten Quartal mehr Autos ab. Salmonellen-Schokolade von Barry Callebaut ist nicht in Läden gelangt. BASF und MAN wollen gemeinsam riesige Wärmepumpe in Ludwigshafen bauen.

Die 5 beliebtesten Top-Rankings

mehr Top Rankings

Umfrage

Goldpreis im Fokus der Anleger: Sind Sie in Gold investiert?

finanzen.net zero
finanzen.net zero

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln